Allergan Target Faces Bid To Halt Vote On $30M Merger
By Ryan Boysen ( January 5, 2018, 4:03 PM EST) -- Reproductive disorder drugmaker Repros Therapeutics Inc. has been hit with a stockholder suit in Delaware federal court that seeks to block a proposed $30 million acquisition by Allergan PLC unless Repros releases more information on how it valued itself ahead of the deal....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.